Geode Capital Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.15 - $0.37 $23,374 - $57,656	155,829 Added 7.3%	2,291,286 $366,000
Q1 2024 May 13, 2024	BUY	$0.19 - $0.3 $106,199 - $167,683	558,944 Added 35.45%	2,135,457 $576,000
Q4 2023 Feb 13, 2024	SELL	$0.12 - $0.64 $46,077 - $245,746	-383,979 Reduced 19.59%	1,576,513 $346,000
Q3 2023 Nov 13, 2023	BUY	$0.12 - $0.41 $184 - $631	1,540 Added 0.08%	1,960,492 $254,000
Q2 2023 Aug 11, 2023	BUY	$0.35 - $0.72 $53,932 - $110,947	154,094 Added 8.54%	1,958,952 $705,000
Q4 2022 Feb 13, 2023	BUY	$0.46 - $42.69 $52,744 - $4.89 Million	114,662 Added 6.78%	1,804,858 $902,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $87,576 - $4.59 Million	139,010 Added 8.96%	1,690,196 $1.07 Million
Q2 2022 Aug 12, 2022	SELL	$0.63 - $0.96 $50,079 - $76,311	-79,491 Reduced 4.87%	1,551,186 $1.23 Million
Q1 2022 May 13, 2022	BUY	$0.5 - $1.06 $21,907 - $46,442	43,814 Added 2.76%	1,630,677 $1.31 Million
Q4 2021 Feb 11, 2022	BUY	$0.92 - $1.22 $176,749 - $234,385	192,119 Added 13.77%	1,586,863 $1.6 Million
Q3 2021 Nov 12, 2021	BUY	$0.67 - $1.51 $50,775 - $114,435	75,785 Added 5.75%	1,394,744 $1.81 Million
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.1 $39,782 - $58,347	53,043 Added 4.19%	1,318,959 $1.02 Million
Q1 2021 May 12, 2021	BUY	$0.96 - $1.74 $138,801 - $251,577	144,585 Added 12.89%	1,265,916 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$0.76 - $1.47 $31,856 - $61,616	41,916 Added 3.88%	1,121,331 $1.53 Million
Q1 2020 May 14, 2020	BUY	$0.6 - $2.31 $126,361 - $486,492	210,603 Added 24.24%	1,079,415 $647,000
Q4 2019 Feb 13, 2020	BUY	$0.63 - $2.27 $40,396 - $145,556	64,122 Added 7.97%	868,812 $1.97 Million
Q3 2019 Nov 12, 2019	BUY	$0.59 - $0.9 $72,191 - $110,122	122,358 Added 17.93%	804,690 $507,000
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $165,359 - $388,594	275,599 Added 67.76%	682,332 $743,000
Q3 2018 Nov 13, 2018	SELL	$0.35 - $0.92 $655 - $1,722	-1,872 Reduced 0.46%	406,733 $374,000
Q2 2018 Aug 14, 2018	SELL	$0.42 - $0.74 $56,783 - $100,047	-135,199 Reduced 24.86%	408,605 $177,000
Q1 2018 May 15, 2018	BUY	$0.76 - $1.32 $11,116 - $19,307	14,627 Added 2.76%	543,804 $415,000
Q4 2017 Feb 13, 2018	BUY	$1.1 - $1.54 $30,373 - $42,522	27,612 Added 5.51%	529,177 $613,000
Q3 2017 Nov 14, 2017	BUY	$1.19 - $1.43 $7,548 - $9,070	6,343 Added 1.28%	501,565 $662,000
Q2 2017 Aug 14, 2017	BUY	N/A	495,222	495,222 $836,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $119M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account